Red wine: health benefits or health harms?

Authors from Peru assert that the myriad advantages of red wine predominantly stem from phenolic compounds, falling into two primary categories: flavonoids and non-flavonoids. Initially, these authors synthesize findings from prior studies, largely sourced from preclinical data. The functionality of phenolic compounds within the human system encompasses several facets: antioxidative, anti-inflammatory, antitumor, antithrombotic, antiatherogenic, and antimicrobial effects. Notably, recent years have witnessed the development of targeted methodologies focused on enhancing the inherent bioactive composition of red wine. Consequently, authors summarize technological approaches aimed to augment the polyphenol content present in red wine. Enhancement strategies include the pre-fermentative, fermentative, and aging stages. While research predominantly examines red wine quality during aging, it's been noted that incorporating polysaccharides pre-alcoholic fermentation yields positive outcomes. Primarily directed at mitigating microbial presence in grape, these technologies concurrently refine the physicochemical characteristics of red wine. Moreover, their application extends to bolstering the array of bioactive compounds in the wine.